CRISPR Therapeutics AG 10-K for FY2023
CRISPR Therapeutics AG (CRSP)
10-K
2024-02-21
For: 2023-12-31
View Original
Added on
April 09, 2026
About this 10-K
CRISPR Therapeutics AG filed this 10-K on February 21, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $371.21M
- up 30885.5% from $1.2M a year earlier
- Net loss
- $153.61M
- compared with a net loss of $650.18M a year earlier
- Diluted EPS
- -$1.94
- compared with -$8.36 a year earlier